Global X Management Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.28M Sell
39,077
-491
-1% -$14.8K 0.02% 400
2018
Q1
$1.08M Buy
39,568
+6,443
+19% +$175K 0.02% 393
2017
Q4
$821K Buy
33,125
+5,269
+19% +$145K 0.02% 423
2017
Q3
$813K Buy
27,856
+3,013
+12% +$83.2K 0.02% 411
2017
Q2
$689K Buy
24,843
+5,610
+29% +$149K 0.02% 427
2017
Q1
$478K Buy
19,233
+3,937
+26% +$95.7K 0.02% 489
2016
Q4
$331K Buy
15,296
+4,179
+38% +$91.2K 0.01% 492
2016
Q3
$265K Buy
11,117
+6,434
+137% +$153K 0.01% 509
2016
Q2
$109K Buy
4,683
+2,242
+92% +$48.5K 0.01% 514
2016
Q1
$46K Buy
2,441
+2,166
+788% +$38K ﹤0.01% 558
2015
Q4
$5K Sell
275
-35
-11% -$627 ﹤0.01% 661
2015
Q3
$5K Sell
310
-19
-6% -$325 ﹤0.01% 740
2015
Q2
$6K Buy
+329
New +$5.88K ﹤0.01% 679

Other funds holding BSX

Global X Management Company's BSX Position: Q2 2018 in Review

Global X Management Company reduced its Boston Scientific (BSX) stake by 1.2% in Q2 2018, selling an estimated $14.8K and leaving 39,077 shares worth $1.28M. The position accounts for 0.02% of the portfolio, ranked #400.

Global X Management Company first reported a position in BSX in Q2 2015 and has held it in 13 quarters since. 671 funds tracked by Wall St. Rank hold BSX as of Q2 2018.

  • Global X Management Company held 39,077 shares of Boston Scientific worth $1.28M as of Q2 2018.
  • Global X Management Company sold 491 Boston Scientific shares in Q2 2018, an estimated $14.8K.
  • Boston Scientific made up 0.02% of Global X Management Company's portfolio in Q2 2018, its #400 holding.
  • Global X Management Company first reported a position in Boston Scientific in Q2 2015 and has held it in 13 quarters since.
  • 671 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.